Palo Alto Investors LP Gossamer Bio, Inc. Transaction History

Palo Alto Investors LP

$442 Million
Q2 2025

A detailed history of Palo Alto Investors LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 5,739,013 shares of GOSS stock, worth $11.1 Million. This represents 1.6% of its overall portfolio holdings.

Number of Shares

5,739,013

Previous 6,276,893 8.57%

Holding current value

$11.1 Million

Previous $6.9 Million 2.23%

% of portfolio

1.6%

Previous 1.38%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.78 - $1.44 $419,546 - $774,547	-537,880 Reduced 8.57%	5,739,013 $7.06 Million
Q1 2025 May 15, 2025	SELL	$0.85 - $1.53 $170 - $306	-200 Reduced -0.0%	6,276,893 $6.9 Million
Q2 2024 Aug 14, 2024	SELL	$0.51 - $1.27 $58,487 - $145,646	-114,682 Reduced 1.79%	6,277,093 $5.65 Million
Q1 2024 May 15, 2024	BUY	$0.8 - $1.51 $346,309 - $653,659	432,887 Added 7.26%	6,391,775 $7.54 Million
Q4 2023 Feb 15, 2024	BUY	$0.48 - $1.08 $1.2 Million - $2.69 Million	2,493,736 Added 71.97%	5,958,888 $5.42 Million
Q4 2023 Feb 14, 2024	SELL	$0.48 - $1.08 $1.47 Million - $3.31 Million	-3,065,136 Reduced 46.94%	3,465,152 $3.15 Million
Q3 2023 Nov 14, 2023	BUY	$0.78 - $1.82 $2.39 Million - $5.58 Million	3,065,136 Added 88.46%	6,530,288 $5.42 Million
Q1 2023 May 15, 2023	BUY	$0.96 - $2.92 $3.29 Million - $10 Million	3,427,402 Added 9079.21%	3,465,152 $4.37 Million
Q4 2022 Feb 14, 2023	SELL	$1.74 - $12.87 $2.98 Million - $22 Million	-1,712,901 Reduced 97.84%	37,750 $81,000
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $36,452 - $60,876	-6,106 Reduced 0.35%	1,750,651 $14.7 Million
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $136,668 - $202,250	-16,193 Reduced 0.91%	1,756,757 $15.2 Million
Q1 2021 May 17, 2021	BUY	$8.63 - $10.94 $292,557 - $370,866	33,900 Added 1.95%	1,772,950 $16.4 Million
Q4 2020 Feb 16, 2021	BUY	$8.3 - $13.59 $5.49 Million - $8.99 Million	661,850 Added 61.44%	1,739,050 $16.8 Million
Q3 2020 Nov 16, 2020	BUY	$11.3 - $14.75 $9.86 Million - $12.9 Million	872,986 Added 427.49%	1,077,200 $13.4 Million
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $1.94 Million - $3.26 Million	204,214 New	204,214 $2.66 Million

Others Institutions Holding GOSS

# of Institutions

137

Shares Held

159M

Call Options Held

2.79M

Put Options Held

130K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $181M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.

Account

Palo Alto Investors LP Gossamer Bio, Inc. Transaction History